Humana Inc. $HUM Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 23.2% during the third quarter, Holdings Channel reports. The firm owned 21,194 shares of the insurance provider’s stock after selling 6,408 shares during the quarter. ProShare Advisors LLC’s holdings in Humana were worth $5,514,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the business. Elevation Point Wealth Partners LLC bought a new stake in shares of Humana during the 2nd quarter valued at about $32,000. Mather Group LLC. acquired a new position in Humana in the third quarter valued at approximately $34,000. AlphaCore Capital LLC acquired a new position in Humana in the second quarter valued at approximately $39,000. Private Wealth Management Group LLC grew its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the last quarter. Finally, SJS Investment Consulting Inc. raised its position in shares of Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HUM has been the subject of a number of analyst reports. Wolfe Research boosted their price objective on Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research report on Thursday, January 8th. Barclays reiterated an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. UBS Group reduced their price target on shares of Humana from $285.00 to $195.00 and set a “neutral” rating for the company in a report on Thursday. Leerink Partners dropped their price objective on shares of Humana from $267.00 to $185.00 and set a “market perform” rating on the stock in a report on Thursday. Finally, Wells Fargo & Company downgraded shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Seven equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $239.46.

Humana Price Performance

Shares of NYSE HUM opened at $183.92 on Friday. The stock has a market cap of $22.12 billion, a P/E ratio of 18.73, a P/E/G ratio of 1.99 and a beta of 0.44. The firm’s 50-day simple moving average is $244.65 and its 200 day simple moving average is $260.85. Humana Inc. has a fifty-two week low of $169.61 and a fifty-two week high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.00 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. During the same quarter in the prior year, the firm posted ($2.16) EPS. Humana’s revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Trending Headlines about Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: CenterWell (Humana’s healthcare services unit) closed the acquisition of MaxHealth, adding a sizable Florida primary‑care network (~82 owned/affiliated clinics and >80,000 patients in value‑based programs) which expands Humana’s senior-focused, value‑based primary care footprint and accelerates revenue and membership growth in higher-value care. CenterWell Completes Acquisition of MaxHealth
• Positive Sentiment: Management signals more primary‑care deals may be coming (CEO remarks and media reports about a potential ~$1B strategic push), reinforcing the company’s strategy to grow value‑based care capacity — a long‑term growth catalyst if Humana can scale clinics and convert MA members to higher‑margin care. Humana CEO hints at upcoming primary care deal
• Neutral Sentiment: Jefferies cut its price target (from $310 to $235) but kept a Buy rating, reflecting disagreement among analysts on Humana’s growth vs. margin tradeoff — some firms still see upside despite lower near‑term earnings visibility. Jefferies price target change
• Negative Sentiment: Several major analysts materially lowered price targets and trimmed estimates (TD Cowen to $173 Hold; JPMorgan to $180 Neutral; Evercore, Cantor, Leerink also cut targets), reflecting concern that Medicare Advantage cost pressures, lower quality (STAR) ratings, and a cautious 2026 earnings guide will weigh on near‑term profitability. TD Cowen PT cut
• Negative Sentiment: Humana reported a fourth‑quarter loss and issued a cautious 2026 outlook (management flagged sharply lower near‑term earnings as Medicare Advantage membership surges but margins remain under pressure), which prompted analysts to slash forecasts and is the primary fundamental reason for downward pressure on the stock. Humana stock falls on disappointing earnings forecast

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.